Mylan Pharms. v. Acorda Therapeutics, 85 U.S.L.W. 3327 (2017).

Mylan Pharms. v. Acorda Therapeutics, 85 U.S.L.W. 3327 (2017). Cases Citing This Book View Copy Cite

neutral Cited (no substantive treatment) 0.9 score

10 citation events (10 in the last 25 years) across 6 distinct courts.

Treatment classes

Mentioned in passing 10

Treatment by court

Retrieving the full opinion text from the archive…

MYLAN PHARMACEUTICALS
v.
ACORDA THERAPEUTICS

No. 16–360..

Supreme Court of the United States.

Jan 9, 2017.

85 U.S.L.W. 3327

Google Scholar ↗ | CourtListener ↗

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.

Consideration, Took.

Published

Justice ALITO took no part in the consideration or decision of this petition.